Health Condition 1: N870- Mild cervical dysplasia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Married women Aged 20 to 60 years 2.Patients with clinical signs and symptoms of Cervical Dysplasia including vaginal white discharge, backache, irregular vaginal spotting or postcoital bleeding 3.Confirmed cases of LSIL in Pap smears 4.Willingness to participate in the study and follow the schedule
Exclusion criteria
Exclusion criteria: 1.Unmarried women 2.Women aged less than 20 and more than 60 years 3.High grade abnormal lesions in Pap smears, HSIL, ASC-H, AGC 4.Associated gynecological pathology like Pelvic inflammatory disease, ovarian tumor, prolapse, polyp. 5.Known cases of systemic disease like Diabetes mellitus, hepatorenal, cardiac , pulmonary disorder Immuno-compromised states (HIV/ AIDS) 6.Pregnant and lactating mother 7.Subjects those who are unwilling to come regular follow ups for the entire duration of study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Topical application of the unani formulation is expected to resolve the cytological changes observe in the Pap smear in patients Low-Grade Squamous Intraepithelial Lesion ?LSILTimepoint: 8 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. To assess the safety and tolerability of topical Unani formulation in patients with Low-Grade Squamous Intraepithelial Lesion (LSIL). 2. To evaluate the potential therapeutic activity of topical Unani formulation in women with LSIL.Timepoint: 8 weeks | — |
Countries
India
Contacts
National Research Institute of Unani medicine for Skin Disorders